MEVINACOR 10 |
SIMVASTATIN IMPURITY, LOVASTATIN- |
L-154803 |
MEVINOLIN |
MEVACOR |
MEVINACOR |
MK-803 |
ALTOPREV |
MEVINACOR 40 |
LOVASTATIN |
C10AA02 |
6-ALPHA-METHYLCOMPACTIN |
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-(2R,4R)-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL (S)-2-METHYL-BUTYRATE |
2Β,6Α-DIMETHYL-8ALPHA-(2-METHYL-1-OXOBUTOXY)-MEVINIC ACID LACTONE |
LOVASTATINA |
LOVASTATINUM |
6ALPHA-METHYLCOMPACTIN |
LOVASTATINE |
6Α-METHYLCOMPACTIN |
chemidplus:75330-75-5 |
pubchem.compound:53232 |
rxcui:6472 |
drugbank:00227 |
chembl:CHEMBL503 |
Year of Approval | 1987 |
Drug Class | anticholesteremic agents |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | anticholesterolaemic agent |
Drug Categories | agents causing muscle toxicity |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | cytochrome p-450 cyp2c19 substrates |
Drug Categories | cytochrome p-450 cyp2c8 inhibitors (moderate) |
Drug Categories | cytochrome p-450 cyp2c8 substrates |
Drug Categories | cytochrome p-450 cyp2c9 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2d6 inhibitors (weak) |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 cyp3a7 substrates |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | hypolipidemic agents indicated for hyperlipidemia |
Drug Categories | oatp1b1/slco1b1 inhibitors |
Drug Categories | oatp1b1/slco1b1 substrates |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | photosensitizing agents |
Drug Categories | ugt1a1 substrates |
Drug Categories | ugt1a3 substrates |
Drug Categories | ugt2b7 substrates |
inhibitor (inhibitory) |
Trial Name | lovastatin,Mevacor, Altocor, Altoprev |
Novel drug target | Established target |
Mechanism of Interaction | HMG-CoA reductase inhibitor |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
LOVASTATIN | DrugBank Drug Name |
75330-75-5 | CAS Number |
Act Lovastatin | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
LOVASTATIN | Primary Drug Name |
Drug Class | anticholesteremic agents |
Year of Approval | 1987 |
Drug Indications | anticholesterolaemic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
C620 | NCI drug code |
CHEMBL503 | ChEMBL Drug ID |
D06WTZ | TTD Drug ID |
LOVASTATIN | GuideToPharmacology Ligand Name |